Vivo Opportunity Fund Holdings, L.p. - Net Worth and Insider Trading
Vivo Opportunity Fund Holdings, L.p. Net Worth
The estimated net worth of Vivo Opportunity Fund Holdings, L.p. is at least $389 Million dollars as of 2024-10-31. Vivo Opportunity Fund Holdings, L.p. is the 10% Owner of Soleno Therapeutics Inc and owns about 6,291,851 shares of Soleno Therapeutics Inc (SLNO) stock worth over $346 Million. Vivo Opportunity Fund Holdings, L.p. is also the 10% Owner of Terns Pharmaceuticals Inc and owns about 6,237,329 shares of Terns Pharmaceuticals Inc (TERN) stock worth over $43 Million. Details can be seen in Vivo Opportunity Fund Holdings, L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Vivo Opportunity Fund Holdings, L.p. has not made any transactions after 2024-08-29 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Vivo Opportunity Fund Holdings, L.p.
Vivo Opportunity Fund Holdings, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Vivo Opportunity Fund Holdings, L.p. owns 4 companies in total, including Sierra Oncology Inc (SRRA) , Terns Pharmaceuticals Inc (TERN) , and Soleno Therapeutics Inc (SLNO) among others .
Insider Ownership Summary of Vivo Opportunity Fund Holdings, L.p.
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
SRRA | Sierra Oncology Inc | 2022-07-01 | director & 10 percent owner |
TERN | Terns Pharmaceuticals Inc | 2024-04-03 | 10 percent owner |
SLNO | Soleno Therapeutics Inc | 2024-08-29 | 10 percent owner |
2023-08-09 | 10 percent owner |
Vivo Opportunity Fund Holdings, L.p. Latest Holdings Summary
Vivo Opportunity Fund Holdings, L.p. currently owns a total of 2 stocks. Among these stocks, Vivo Opportunity Fund Holdings, L.p. owns 6,291,851 shares of Soleno Therapeutics Inc (SLNO) as of August 29, 2024, with a value of $346 Million and a weighting of 89.01%. Vivo Opportunity Fund Holdings, L.p. also owns 6,237,329 shares of Terns Pharmaceuticals Inc (TERN) as of April 3, 2024, with a value of $43 Million and a weighting of 10.99%.
Latest Holdings of Vivo Opportunity Fund Holdings, L.p.
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
SLNO | Soleno Therapeutics Inc | 2024-08-29 | 6,291,851 | 55.06 | 346,429,316 |
TERN | Terns Pharmaceuticals Inc | 2024-04-03 | 6,237,329 | 6.86 | 42,788,077 |
Holding Weightings of Vivo Opportunity Fund Holdings, L.p.
Vivo Opportunity Fund Holdings, L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Vivo Opportunity Fund Holdings, L.p. has made a total of 2 transactions in Soleno Therapeutics Inc (SLNO) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Soleno Therapeutics Inc is the sale of 1,025,000 shares on August 29, 2024, which brought Vivo Opportunity Fund Holdings, L.p. around $49 Million.
According to the SEC Form 4 filings, Vivo Opportunity Fund Holdings, L.p. has made a total of 4 transactions in Terns Pharmaceuticals Inc (TERN) over the past 5 years, including 3 buys and 1 sells. The most-recent trade in Terns Pharmaceuticals Inc is the sale of 420,663 shares on April 3, 2024, which brought Vivo Opportunity Fund Holdings, L.p. around $3 Million.
Insider Trading History of Vivo Opportunity Fund Holdings, L.p.
- 1
Vivo Opportunity Fund Holdings, L.p. Trading Performance
GuruFocus tracks the stock performance after each of Vivo Opportunity Fund Holdings, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Vivo Opportunity Fund Holdings, L.p. is 19.35%. GuruFocus also compares Vivo Opportunity Fund Holdings, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Vivo Opportunity Fund Holdings, L.p. within 3 months outperforms 3 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Vivo Opportunity Fund Holdings, L.p.'s insider trading performs compared to the benchmark.
Performance of Vivo Opportunity Fund Holdings, L.p.
Vivo Opportunity Fund Holdings, L.p. Ownership Network
Ownership Network List of Vivo Opportunity Fund Holdings, L.p.
Ownership Network Relation of Vivo Opportunity Fund Holdings, L.p.
Vivo Opportunity Fund Holdings, L.p. Owned Company Details
What does Sierra Oncology Inc do?
Who are the key executives at Sierra Oncology Inc?
Vivo Opportunity Fund Holdings, L.p. is the director & 10 percent owner of Sierra Oncology Inc. Other key executives at Sierra Oncology Inc include Chief Reg & Tech Ops Officer William D. Turner , General Counsel Mary Christina Thomson , and director & 10 percent owner Joshua Richardson .
Sierra Oncology Inc (SRRA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Sierra Oncology Inc (SRRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sierra Oncology Inc (SRRA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Sierra Oncology Inc (SRRA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sierra Oncology Inc Insider Transactions
Vivo Opportunity Fund Holdings, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Vivo Opportunity Fund Holdings, L.p.. You might contact Vivo Opportunity Fund Holdings, L.p. via mailing address: 192 Lytton Avenue, Palo Alto Ca 94301.